{"doc_id": "si-2025-0406-reg-1", "parent_doc_id": "si-2025-0406", "section_id": "reg-1", "section_label": "Regulation 1.", "si_number": "S.I. No. 406 of 2025", "title": "2022) effected by Article 2 of the following order to be unlawful", "year": 2025, "heading": "1. This Order may be cited as the Misuse of Drugs Act 1977 (Controlled", "text_raw": "1. This Order may be cited as the Misuse of Drugs Act 1977 (Controlled \n\nDrugs) (Designation) (Amendment) Order 2025.", "text_norm": "1 order may cited misuse drug act 1977 (controlled drugs) (designation) (amendment) order 2025", "start_char": 1520, "end_char": 1640, "source_path": "downloads\\2025\\2025_0406.pdf", "extraction_method": "pdfminer", "checksum": "sha256:25c386287b3409c374f0d96a90784b40ba8f118ae5bec43ba252df2badda5b11", "cross_refs": []}
{"doc_id": "si-2025-0406-reg-2", "parent_doc_id": "si-2025-0406", "section_id": "reg-2", "section_label": "Regulation 2.", "si_number": "S.I. No. 406 of 2025", "title": "2022) effected by Article 2 of the following order to be unlawful", "year": 2025, "heading": "2. Schedule 1 to the Misuse of Drugs Act 1977 (Controlled Drugs)", "text_raw": "2. Schedule 1 to the Misuse of Drugs Act 1977 (Controlled Drugs) \n(Designation) Order 2022 (S.I. No. 211 of 2022) is amended, in paragraph 1(a), \nby – \n\n(a) \n\n(b) \n\nthe insertion of “N-[1-(Aminocarbonyl)-2,2-dimethylpropyl]-1butyl-1H-indazole-3-carboxamide (otherwise known as ADBBUTINACA)” after “N-(Adamantan-1-yl)-1-(5-fluoropentyl)1H-indazole-3-carboxamide (otherwise known as Clockwork \nOrange, 5F AKB48)”, \n\nthe insertion of “N,N-diethyl-2-[(4-butoxyphenyl)methyl]-5nitro-1H-benzimidazole-1-ethanamine (otherwise known as \nButonitazene)” after “[2,3-Dihydro-5-methyl-3-(4morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1naphthalenylmethanone”, \n\n (c) \n\nthe insertion of “N,N-diethyl-5-nitro-2-[(4propoxyphenyl)methyl]-1-H-benzimidazole-1-ethanamine \n\nNotice of the making of this Statutory Instrument was published in \n\"Iris Oifigiúil\" of 22nd August, 2025. \n\n \n \n \n \n \n\f[406] 3 \n\n(otherwise known as Protonitazene)” after “N,N-Diethyl-2-(2-\n(4-isopropoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)ethan1-amine (otherwise known as Isotonitazene)”, \n\n(d) \n\nthe insertion of the following after “1-(1,2Diphenylethyl)piperidine (otherwise known as Diphenidine)”: \n\n“2-[(4-Ethoxyphenyl)methyl]-N,N-diethyl-1H-benzimidazole-1ethanamine (otherwise known as Etazene) \n\n2-[(4-Ethoxyphenyl)methyl]-5-nitro-1-(2-piperidin-1-ylethyl)1H-benzoimidazole (otherwise known as Etonitazepipne) \n\n2-[(4-Ethoxyphenyl)methyl]-5-nitro-1-(2-pyrrolidin-1-ylethyl)1H-benzoimidazole (otherwise known as Etonitazepyne) \n\nN-ethyl-2-[2-[(4-isopropoxyphenyl)methyl]-5-nitrobenzimidazol-1-yl]ethanamine (otherwise known as N-desethyl \nisotonitazene)”, \n\n(e) \n\nthe insertion of “2-(2-fluorophenyl)-2-\n(methylamino)cyclohexan-1-one (otherwise known as 2Fluorodeschloroketamine)” after “[1-(5-Fluoropentyl)-1H-indol3-yl](2,2,3,3-tetramethylcyclopropyl)methanone (otherwise \nknown as XLR-11)”, \n\n(f) \n\nthe insertion of the following after “1-(4-Fluorophenyl)-2methylaminopropan-1-one”: \n\n“6a,7,8,9,10,10a-hexahydro-6,6,9-trimethyl-3-pentyl-6Hdibenzo[b,d]pyran-1-ol (otherwise known as \nHexahydrocannabinol) \n\nHexahydro derivatives of 3-alkyl homologues of cannabinol”, \n\n(g) \n\nthe insertion of “2-[(4-methoxyphenyl)methyl]-5-nitro-1-(2pyrrolidin-1-ylethyl)-1H-benzoimidazole (otherwise known as \nMetonitazepyne)” after “1-(4-Methoxyphenyl)-2-\n(methylamino)propan-1-one”, and \n\n(h) \n\nthe insertion of the following after “1-(4-Methylphenyl)-2methylaminopropan-1-one”: \n\n“1-{2-methyl-4-[(2E)-3-phenylprop-2-en-1-yl]piperazin-1yl}butan-1-one (otherwise known as 2-methyl-AP-237) \n\n5-nitro-2-[(4-propoxyphenyl)methyl]-1-(2-pyrrolidin-1ylethyl)benzimidazole (otherwise known as Protonitazepyne)”. \n\nGIVEN under my Official Seal, \n29 July, 2025. \n\nJENNIFER CARROLL MACNEILL, \nMinister for Health. \n\n \n \n \n \n \n\f4 [406] \n\nBAILE ÁTHA CLIATH \nARNA FHOILSIÚ AG OIFIG AN tSOLÁTHAIR \nLe ceannach díreach ó \nFOILSEACHÁIN RIALTAIS, \nBÓTHAR BHAILE UÍ BHEOLÁIN, \nCILL MHAIGHNEANN, \nBAILE ÁTHA CLIATH 8, \nD08 XAO6 \n\nTeil: 046 942 3100 \nr-phost: publications@opw.ie \n—————— \n\nDUBLIN \nPUBLISHED BY THE STATIONERY OFFICE \nTo be purchased from \nGOVERNMENT PUBLICATIONS, \nMOUNTSHANNON ROAD, \nKILMAINHAM, DUBLIN 8, \nD08 XAO6 \n\nTel: 046 942 3100 \nE-mail: publications@opw.ie \n—————— \n\n€ 1.50 \n\n(DH-598) 30. 7/25. Propylon.", "text_norm": "2 schedule 1 misuse drug act 1977 (controlled drugs) (designation) order 2022 (s.i no 211 2022) amended paragraph 1(a) - (a) (b) insertion n- 1-(aminocarbonyl)-2 2-dimethylpropyl -1butyl-1h-indazole-3-carboxamide (otherwise known adbbutinaca) n-(adamantan-1-yl)-1-(5-fluoropentyl)1h-indazole-3-carboxamide (otherwise known clockwork orange 5f akb48) insertion n n-diethyl-2- (4-butoxyphenyl)methyl -5nitro-1h-benzimidazole-1-ethanamine (otherwise known butonitazene) 2 3-dihydro-5-methyl-3-(4morpholinylmethyl)pyrrolo 1 2 3-de -1 4-benzoxazin-6-yl -1naphthalenylmethanone (c) insertion n n-diethyl-5-nitro-2- (4propoxyphenyl)methyl -1-h-benzimidazole-1-ethanamine notice making statutory instrument published iris oifigiuil 22nd august 2025 406 3 (otherwise known protonitazene) n n-diethyl-2-(2- (4-isopropoxybenzyl)-5-nitro-1h-benzo imidazol-1-yl)ethan1-amine (otherwise known isotonitazene) (d) insertion following 1-(1 2diphenylethyl)piperidine (otherwise known diphenidine) 2- (4-ethoxyphenyl)methyl -n n-diethyl-1h-benzimidazole-1ethanamine (otherwise known etazene) 2- (4-ethoxyphenyl)methyl -5-nitro-1-(2-piperidin-1-ylethyl)1h-benzoimidazole (otherwise known etonitazepipne) 2- (4-ethoxyphenyl)methyl -5-nitro-1-(2-pyrrolidin-1-ylethyl)1h-benzoimidazole (otherwise known etonitazepyne) n-ethyl-2- 2- (4-isopropoxyphenyl)methyl -5-nitrobenzimidazol-1-yl ethanamine (otherwise known n-desethyl isotonitazene) (e) insertion 2-(2-fluorophenyl)-2- (methylamino)cyclohexan-1-one (otherwise known 2fluorodeschloroketamine) 1-(5-fluoropentyl)-1h-indol3-yl (2 2 3 3-tetramethylcyclopropyl)methanone (otherwise known xlr-11) (f) insertion following 1-(4-fluorophenyl)-2methylaminopropan-1-one 6a 7 8 9 10 10a-hexahydro-6 6 9-trimethyl-3-pentyl-6hdibenzo b pyran-1-ol (otherwise known hexahydrocannabinol) hexahydro derivative 3-alkyl homologues cannabinol (g) insertion 2- (4-methoxyphenyl)methyl -5-nitro-1-(2pyrrolidin-1-ylethyl)-1h-benzoimidazole (otherwise known metonitazepyne) 1-(4-methoxyphenyl)-2- (methylamino)propan-1-one (h) insertion following 1-(4-methylphenyl)-2methylaminopropan-1-one 1- 2-methyl-4- (2e)-3-phenylprop-2-en-1-yl piperazin-1yl butan-1-one (otherwise known 2-methyl-ap-237) 5-nitro-2- (4-propoxyphenyl)methyl -1-(2-pyrrolidin-1ylethyl)benzimidazole (otherwise known protonitazepyne)  given official seal 29 july 2025 jennifer carroll macneill minister health 4 406 baile atha cliath arna fhoilsiu ag oifig tsolathair le ceannach direach foilseachain rialtais bothar bhaile ui bheolain cill mhaighneann baile atha cliath 8 d08 xao6 teil 046 942 3100 r-phost publication opw.ie ------------ dublin published stationery office purchased government publication mountshannon road kilmainham dublin 8 d08 xao6 tel 046 942 3100 e-mail publication opw.ie ------------ eur 1.50 (dh-598) 30 7 25 propylon", "start_char": 1640, "end_char": 4915, "source_path": "downloads\\2025\\2025_0406.pdf", "extraction_method": "pdfminer", "checksum": "sha256:25c386287b3409c374f0d96a90784b40ba8f118ae5bec43ba252df2badda5b11", "cross_refs": []}
